Your browser doesn't support javascript.
[Progress in epidemiological research of 2019-nCoV infection and COVID-19 vaccination in pregnancy].
Yang, J T; Liu, Z K; Zhan, S Y.
  • Yang JT; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Key Laboratory for Research and Evaluation of Pharmacovigilance, National Medical Products Administration, Peking University,Beijing 100191, China.
  • Liu ZK; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Key Laboratory for Research and Evaluation of Pharmacovigilance, National Medical Products Administration, Peking University,Beijing 100191, China.
  • Zhan SY; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Key Laboratory for Research and Evaluation of Pharmacovigilance, National Medical Products Administration, Peking University,Beijing 100191, China Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China Center for Intelligent Public Health, Institute for Artificial Intelligence, Peking University, Beijing 100871, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(8): 1215-1221, 2022 Aug 10.
Article in Chinese | MEDLINE | ID: covidwho-1994240
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by 2019-nCoV. Due to the physiological change in pregnancy, pregnant women are susceptible to COVID-19 and are at increased risk for adverse pregnancy outcomes, especially in the context of spread of novel variants. At present, less evidences have been obtained from randomized controlled trials on the effectiveness and safety of COVID-19 vaccine use in pregnant women, and the recommendations of COVID-19 vaccination for pregnant women vary with countries, posing challenge to the prevention and control of COVID-19 in pregnant women. This paper summarizes the progress in major research of 2019-nCoV infection in pregnancy conducted both at home and abroad, describes the harm of COVID-19 in pregnancy to pregnant women, fetuses and infants and introduces the effectiveness and safety of COVID-19 vaccination in pregnancy revealed by real world studies in order to provide reference for the related research and development of COVID-19 prevention and control strategies in pregnant women.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Female / Humans / Infant / Pregnancy Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112338-20220323-00217

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Female / Humans / Infant / Pregnancy Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2022 Document Type: Article Affiliation country: Cma.j.cn112338-20220323-00217